Literature DB >> 1161240

Carcinoma in situ of the vagina. A study and review.

D G Gallup, G W Morley.   

Abstract

A retrospective study has been carried out on 25 patients treated at the University of Michigan Medical Center for carcinoma in situ of the vagina. Intraepithelial carcinoma of the vagina occurred as a primary entity, following treatment for preinvasive and invasive carcinoma of the cervix, and following hysterectomy for benign disease of the uterus. These patients were treated with either radium implantation or some form of surgery. Five patients had recurrences. These 5 were all subsequently retreated and are alive and without evidence of further recurrent neoplasm. This series of carcinoma in situ of the vagina is compared to other reported series. Emphasis is directed toward the need for continued use of Papanicolaou smear cytology tests in posthysterectomy patients, regardless of the reason for hysterectomy.

Entities:  

Mesh:

Year:  1975        PMID: 1161240

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Vaginal cytology following primary hysterectomy for cervical cancer: is it useful?

Authors:  C Coughlan; F McAuliffe; N Bermingham; N Gleeson
Journal:  Ir J Med Sci       Date:  2006 Jan-Mar       Impact factor: 1.568

2.  The utility of the human papillomavirus DNA load for the diagnosis and prediction of persistent vaginal intraepithelial neoplasia.

Authors:  Kyeong A So; Jin-Hwa Hong; Jong Ha Hwang; Seung-Hun Song; Jae-Kwan Lee; Nak Woo Lee; Kyu Wan Lee
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

3.  Microinvasive squamous cell carcinoma of the vagina.

Authors:  M M Dini; J M Park
Journal:  J Natl Med Assoc       Date:  1984-07       Impact factor: 1.798

4.  Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia.

Authors:  Ju-Hyun Kim; Jooyoung Kim; Kidong Kim; Jae Hong No; Yong Beom Kim; Dong Hoon Suh
Journal:  J Low Genit Tract Dis       Date:  2022-04-01       Impact factor: 1.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.